newsfilter
← Latest News
GlobeNewswire·

Minerva Neurosciences to Participate in 2026 Jefferies Global Healthcare Conference in London

  • Minerva Neurosciences, Inc. will participate in the 2026 Jefferies Global Healthcare Conference in London.
  • The conference is scheduled for Monday, November 16 & Tuesday, November 17, 2026.
  • Management will attend a fireside chat on Monday, November 16, 2026 from 4:00 – 4:25 p.m. GMT.
  • The event will include fireside chat sessions & one-on-one meetings.
  • A live webcast of the fireside chat will be available on the company website, with a replay accessible approximately two hours after the event concludes.
  • Minerva is a clinical-stage biopharmaceutical company developing therapies for central nervous system disorders.
  • The company is currently conducting a confirmatory Phase 3 trial with roluperidone for negative symptoms of schizophrenia.